Area:
Animal Physiology Biology, Oncology, Molecular Biology
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Fernand Labrie is the likely recipient of the following grants.
| Years |
Recipients |
Code |
Title / Keywords |
Matching
score |
| 1995 |
Labrie, Fernand |
R13Activity Code Description:
To support recipient sponsored and directed international, national or regional meetings, conferences and workshops. |
Fifth International Congress On Hormones and Cancer
Approximately 33% of all human cancers are directly influenced by hormone receptors or their ligands. Moreover, a usual characteristic of these malignant tumors is a disregulation in signal transduction pathways or a dysfunction of genes normally regulated by growth factors, cytokines or hormonal signals. The wealth of information generated by the powerful techniques of molecular biology is rapidly showing a much clearer picture of the chain of cellular events which lead to disregulation of normal gene expression and malignant transformation. At the same time, the unavoidable degree of specialization reached in various sectors of endocrine research makes it increasingly important for endocrinologists on one hand, and cell biologists, on the other hand, to integrate key developments in an interdisciplinary approach. It is the purpose of this conference to gather leading researchers in both the fundamental and clinical aspects of oncology, endocrinology and cell biology and thus stimulate interactions between various specialists concerned with the problem of cancer, endocrinology and therapy of hormone-sensitive cancers. The proposed symposia at this conference will encompass 3 general themes, namely (1) the basic developments in cell biology which have general and direct relevance to cancer in general, (2) recent progress in the use of antihormones and enzyme inhibitors in hormone-sensitive cancer therapy, and (3) a coverage of the most significant developments in the understanding of the 2 main hormone-related human malignancies, namely breast and prostate cancer.
|
0.966 |